Clinical Trials Browser

Completed × Has results × Glutamine × Clear all

NCT01607879 2023-09-22

Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation

Phase 2 Completed

48 enrolled 15 charts

EndocrineGenitourinary

Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT01179217 2020-08-19

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Phase 3 Completed

230 enrolled 19 charts 1 FDA

Classical hematology

Vaso-Occlusive Crises, Anemia, Sickle Cell

NCT01983969 2020-01-27

Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma

Phase 1/2 Completed

61 enrolled 10 charts

Lymphoma, Lymphoma, Non-Hodgkin

NCT00195013 2018-06-06

Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy

Phase 3 Completed

30 enrolled 5 charts

Breast Neoplasms, Peripheral Nervous System Diseases

NCT00365768 2016-09-09

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Phase 2 Completed

56 enrolled 5 charts

GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Kidney Neoplasms, Leukemia, Lymphoma, Wilms Tumor, Peripheral Nervous System Diseases, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Neurotoxicity Syndromes, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating